Henry Schein, Inc.
HSIC Healthcare Medical Distribution
Henry Schein, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $13.2 billion, up 4.03% from fiscal 2024. In the quarter to June 2026, revenue grew 6.73%, EPS grew 16.9%, free cash flow grew 140.9% and total debt rose 15.2%, each against the same quarter a year earlier. Member of the S&P 500; insiders bought in the last twelve months.
Follow HSIC
Henry Schein, Inc. (HSIC) Revenue growth
Henry Schein, Inc.'s revenue growth over the twelve months to 30 June 2026 was 6.49%, up 2.5 percentage points from fiscal 2025 (4.03%). Over the past ten years it has ranged from −23.2% (fiscal 2017) to 22.6% (fiscal 2021); the current reading is higher than 64% of that period. That is below the Medical Distribution industry median of 11.5% and below the Healthcare sector median of 8.27%.
Revenue growth, annual
Embed this chart
Annual newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| FY2025 | 4.03% | 1.32 |
| FY2024 | 2.71% | 5.15 |
| FY2023 | −2.44% | (4.42) |
| FY2022 | 1.98% | (20.57) |
| FY2021 | 22.6% | 21.22 |
| FY2020 | 1.33% | (4.70) |
| FY2019 | 6.03% | 0.02 |
| FY2018 | 6.01% | 29.24 |
| FY2017 | −23.2% | (32.09) |
| FY2016 | 8.86% | 6.37 |
Quarterly newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| Jun 2026 | 6.73% | 0.42 |
| Mar 2026 | 6.31% | (1.40) |
| Dec 2025 | 7.71% | 2.51 |
| Sep 2025 | 5.20% | 1.88 |
| 42 more quarters | Free account |
Against its own ten years
Revenue growth against peers
| Company | Revenue growth |
|---|---|
| ACH Accendra Health, Inc. compare | 247.0% |
| AHG Akso Health Group Sponsored ADR compare | 208.4% |
| COSM Cosmos Health Inc. compare | 33.8% |
| FOCL FocalTherics compare | 29.5% |
| CAH Cardinal Health, Inc. compare | 14.2% |
| MCK McKesson Corporation compare | 8.84% |
| HSIC Henry Schein, Inc. | 6.49% |
| COR Cencora, Inc. compare | 5.09% |
| HKPD Cellyan Biotechnology Co., Ltd compare | — |
| Medical Distribution industry median | 11.5% |
| Healthcare sector median | 8.27% |
| Market median | 7.41% |
What Revenue growth is
Revenue Growth shows how fast a company’s sales are rising or falling compared with the same period a year earlier.
(Revenue − Revenue a year earlier) ÷ |Revenue a year earlier|
More on HSIC
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement